Filed: 11/12/2024ACC: 0001381843-24-000008
📋 What this filing means
ATLE FUND MANAGEMENT AB filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $212.75M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$212.75M
Total AUM (reported)
3.58M
Total Shares
Allocation by class
COM$194.92M91.6%
SHS$6.62M3.1%
COMMON STOCK$3.36M1.6%
SPON ADS$2.43M1.1%
ORDINARY SHARES$2.31M1.1%
ADS$1.68M0.8%
COM NEW$1.44M0.7%
Portfolio Concentration
Top 3$65.40M30.7%
4–10$65.23M30.7%
11–25$67.87M31.9%
Rest$14.25M6.7%
Top 3 weight
30.7%
Top 10 weight
61.4%
Voting Authority Distribution
Total shares with voting rights: 212.75M
Sole
Full voting authority
212.75M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
ELI LILLY & CO
SOLEShares30.56K
TypeSH
Market value$27.08M
12.73%
Sole
27.08M
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares35.49K
TypeSH
Market value$20.75M
9.75%
Sole
20.75M
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares154.70K
TypeSH
Market value$17.57M
8.26%
Sole
17.57M
Shared
0.00
None
0.00
THERMO FISHER SCIENTIFIC INC
SOLEShares22.01K
TypeSH
Market value$13.62M
6.40%
Sole
13.62M
Shared
0.00
None
0.00
AMGEN INC
SOLEShares28.96K
TypeSH
Market value$9.33M
4.39%
Sole
9.33M
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares106.17K
TypeSH
Market value$8.90M
4.18%
Sole
8.90M
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares44.49K
TypeSH
Market value$8.79M
4.13%
Sole
8.79M
Shared
0.00
None
0.00
STRYKER CORPORATION
SOLEShares23.46K
TypeSH
Market value$8.48M
3.98%
Sole
8.48M
Shared
0.00
None
0.00
CENCORA INC
SOLEShares36.54K
TypeSH
Market value$8.23M
3.87%
Sole
8.23M
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares16.99K
TypeSH
Market value$7.90M
3.71%
Sole
7.90M
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares7.03K
TypeSH
Market value$7.39M
3.47%
Sole
7.39M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares60.61K
TypeSH
Market value$6.98M
3.28%
Sole
6.98M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares236.61K
TypeSH
Market value$6.62M
3.11%
Sole
6.62M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares84.58K
TypeSH
Market value$6.19M
2.91%
Sole
6.19M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares151.88K
TypeSH
Market value$6.08M
2.86%
Sole
6.08M
Shared
0.00
None
0.00
UFP TECHNOLOGIES INC
SOLEShares18.05K
TypeSH
Market value$5.72M
2.69%
Sole
5.72M
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares138.32K
TypeSH
Market value$5.39M
2.54%
Sole
5.39M
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares53.76K
TypeSH
Market value$3.60M
1.69%
Sole
3.60M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares40.23K
TypeSH
Market value$3.36M
1.58%
Sole
3.36M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares82.69K
TypeSH
Market value$3.31M
1.56%
Sole
3.31M
Shared
0.00
None
0.00
CARDINAL HEALTH INC
SOLEShares27.50K
TypeSH
Market value$3.04M
1.43%
Sole
3.04M
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares275.47K
TypeSH
Market value$2.94M
1.38%
Sole
2.94M
Shared
0.00
None
0.00
MERUS N V
SOLEShares50.69K
TypeSH
Market value$2.53M
1.19%
Sole
2.53M
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
SOLEShares36.51K
TypeSH
Market value$2.41M
1.13%
Sole
2.41M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares138.98K
TypeSH
Market value$2.31M
1.08%
Sole
2.31M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ELI LILLY & COSOLE | COM | 30.56K | SH | $27.08M 12.73% | 27.08M | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 35.49K | SH | $20.75M 9.75% | 20.75M | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 154.70K | SH | $17.57M 8.26% | 17.57M | 0.00 | 0.00 |
THERMO FISHER SCIENTIFIC INCSOLE | COM | 22.01K | SH | $13.62M 6.40% | 13.62M | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 28.96K | SH | $9.33M 4.39% | 9.33M | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 106.17K | SH | $8.90M 4.18% | 8.90M | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 44.49K | SH | $8.79M 4.13% | 8.79M | 0.00 | 0.00 |
STRYKER CORPORATIONSOLE | COM | 23.46K | SH | $8.48M 3.98% | 8.48M | 0.00 | 0.00 |
CENCORA INCSOLE | COM | 36.54K | SH | $8.23M 3.87% | 8.23M | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 16.99K | SH | $7.90M 3.71% | 7.90M | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 7.03K | SH | $7.39M 3.47% | 7.39M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 60.61K | SH | $6.98M 3.28% | 6.98M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 236.61K | SH | $6.62M 3.11% | 6.62M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 84.58K | SH | $6.19M 2.91% | 6.19M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 151.88K | SH | $6.08M 2.86% | 6.08M | 0.00 | 0.00 |
UFP TECHNOLOGIES INCSOLE | COM | 18.05K | SH | $5.72M 2.69% | 5.72M | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 138.32K | SH | $5.39M 2.54% | 5.39M | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 53.76K | SH | $3.60M 1.69% | 3.60M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 40.23K | SH | $3.36M 1.58% | 3.36M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 82.69K | SH | $3.31M 1.56% | 3.31M | 0.00 | 0.00 |
CARDINAL HEALTH INCSOLE | COM | 27.50K | SH | $3.04M 1.43% | 3.04M | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 275.47K | SH | $2.94M 1.38% | 2.94M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 50.69K | SH | $2.53M 1.19% | 2.53M | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPSOLE | COM | 36.51K | SH | $2.41M 1.13% | 2.41M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 138.98K | SH | $2.31M 1.08% | 2.31M | 0.00 | 0.00 |
Page 1 of 2